---
title: "Impaired Risk Review: Nonalcoholic Fatty Liver Disease (NASH)"
date: 2015-01-06T21:06:23+0000
author: matt
draft: True
---
NASH affects between 2 and 5 percent of Americans and is not always a benign disease or an incidental finding. Along with hepatitis B and hepatitis C, it is attracting large amounts of research dollars in the study of its prevention and treatment.

http://www.brokerworldmag.com/articles/articles.php?articleid=3696
